Emergency Department

September 12, 2019

WellStar Health System Expands Use of Glytec’s eGlycemic Management System®

Georgia’s largest health system is heightening the safety and efficacy of insulin therapy across its network of hospitals.

Known nationally for innovative care models, WellStar Health System, in partnership with Glytec, is taking proactive measures to optimize glycemic management for hospitalized patients. The not-for-profit health system is expanding use of Glytec’s patented and FDA-cleared eGlycemic Management System® (eGMS®) beyond its two largest facilities, WellStar Kennestone Hospital and WellStar Atlanta Medical Center, to an additional eight facilities in the Greater Atlanta and surrounding area.

October 5, 2016

CHI Franciscan Updating Glucose Management Tools, Seeking Robust EHR Integration

CHI Franciscan Health is preparing to implement a new SaaS-based glucose management system that offers proprietary insulin dosing algorithms, analytics and reporting, automated surveillance and alerting, but the real selling point was more seamless EHR integration.

The perceived value of medical devices and ancillary software systems is increasingly tied to how seamlessly they integrate with EHR platforms from Epic or Cerner. That was the case when CHI Franciscan Health in Tacoma, Wash., recently evaluated glucose management systems. One key reason the eight-hospital system chose to implement Glytec’s eGlycemic Management System (eGMS) was its robust integration with Epic.

September 22, 2016

CHI Franciscan Health Selects Glytec’s eGMS® for Precision Diabetes Management

The eGMS® solution suite includes real-time insulin dosing, robust analytics and reporting, automated surveillance and alerting, clinical transformation services, and more.

CHI Franciscan Health of Tacoma, Washington has recently turned to Glytec for its comprehensive eGlycemic Management System®, or eGMS®, which includes FDA-cleared technology for both intravenous and subcutaneous real-time insulin dosing.

June 16, 2016

Glytec’s Glucommander and eGlycemic Management System Featured in Five Studies Presented at The American Diabetes Association’s 76th Scientific Sessions

Wide range of studies further demonstrates significant impact in the emergency department, hospital and outpatient settings.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions, today announced that the company has presented five abstracts addressing a range of issues related to diabetes care at the American Diabetes Association’s 76th Scientific Sessions in New Orleans, Louisiana, June 10-14, 2016. The American Diabetes Association (ADA) brings together global leaders to discuss advancements in diabetes research and care.

May 16, 2016

Orange Regional Medical Center Receives HIMSS Stage 7 Award Based Largely on Glytec’s Insulin Decision Support Solution

Our client, Orange Regional Medical Center, received a HIMSS Analytics Stage 7 Award based largely on its success implementing Glytec’s eGlycemic Management System® to support computer-based precision insulin dosing.

HIMSS Analytics® awarded Orange Regional Medical Center (ORMC), in Middletown, N.Y., with a Stage 7 Award. The award represents ORMC’s attainment of the highest level on the Electronic Medical Record Adoption Model (EMRAM)℠.

March 12, 2016

Hospital Admissions Slashed with Diabetes Software

The use of insulin management software in hospital emergency departments can decrease hospital admissions for diabetic ketoacidosis (DKA) by 45%, according to a new study.

Hospital admissions were reduced by starting patients on IV insulin using Glucommander, a cloud-based insulin management software system, according to a new study. The study, conducted by researchers at Eastern Virginia Medical School, was published in Diabetes Technology & Therapeutics.

February 10, 2016

New Study Demonstrates Effectiveness and Cost Savings of Glytec’s Cloud-Based Decision Support System to Treat Diabetic Ketoacidosis in the Emergency Department

Study leveraging Glytec’s Glucommander IV demonstrated a lower rate of admissions and future hospitalizations, resulting in a cost savings of $78,000 within 12 months.

Glytec, the pioneer and leader in providing innovative glucose decision support software solutions for effective diabetes management, is pleased to share the results of a study conducted in collaboration with Wake Forest Medical School, Eastern Virginia Medical School, and Sentara Healthcare. The study demonstrated intensive insulin therapy used in emergency departments (ED) is useful in treating patients with mild to moderate diabetic ketoacidosis (DKA), resulting in a lower rate of admissions and future admissions to the hospital along with significant cost savings.

June 4, 2015

37 More Hospitals Elect to Strengthen Their Diabetes Management Programs with Glytec

Company continues dramatic growth driven by its unprecedented, proven results.

Glytec, the pioneer and leader in providing innovative, FDA-cleared glucose management software solutions central to effective diabetes management, announces 13 additional health systems across the U.S. have recently selected the company’s eGlycemic Management System® (eGMS®). Collectively, they represent 37 new hospital implementations. eGMS® enables providers, payers, and patients to control glucose levels, and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia.